Literature DB >> 28034895

Impaired Aortic Contractility to Uridine Adenosine Tetraphosphate in Angiotensin II-Induced Hypertensive Mice: Receptor Desensitization?

Zhichao Zhou1,2, Vishal R Yadav1, Changyan Sun1,3, Bunyen Teng1, Jamal S Mustafa1.   

Abstract

OBJECTIVE: We previously showed that uridine adenosine tetraphosphate (Up4A)-mediated aortic contraction is partly mediated through purinergic P2X1 receptors (P2X1R). It has been reported that the plasma level of Up4A is elevated in hypertensive patients, implying a potential role for Up4A-P2X1R signaling in hypertension. This study investigated the vasoactive effect of Up4A in aortas isolated from angiotensin (Ang) II-infused (21 days) hypertensive mice.
METHODS: Blood pressure was measured by tail cuff plethysmography. Aortas were isolated for isometric tension measurements, and protein expression was analyzed by western blot.
RESULTS: Mean and systolic arterial pressures were elevated by ~50% in Ang II-infused mice. Protein levels of both AT1R and P2X1R were upregulated in Ang II-infused aortas. Surprisingly, Up4A (10-9-10-5 M)-induced concentration-dependent contraction was significantly impaired in Ang II-infused mice. Studies in control mice revealed that both P2X1R (MRS2159) and AT1R (losartan) antagonists significantly attenuated Up4A-induced aortic contraction. In addition, desensitization of AT1R by prior Ang II (100 nM) exposure had no effect on Up4A-induced aortic contraction. However, subsequent serial exposure responses to Up4A-induced aortic contraction were markedly reduced, suggesting a desensitization of purinergic receptors. This desensitization was further confirmed in control mice by prior exposure of aortas to the P2X1R desensitizer α, β-methylene ATP (10 μM).
CONCLUSION: Despite upregulation of AT1R and P2X1R in hypertension, Up4A-mediated aortic contraction was impaired in Ang II-infused mice, likely through the desensitization of P2X1R but not AT1R. This implies that vascular P2X1R activity, rather than plasma Up4A level, may determine the role of Up4A in hypertension. © American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  P2X1R; Up4A.; angiotensin II; blood pressure; contraction; hypertension; receptor desensitization

Mesh:

Substances:

Year:  2017        PMID: 28034895      PMCID: PMC5861566          DOI: 10.1093/ajh/hpw163

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  54 in total

1.  Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery.

Authors:  Yu Gui; Michael P Walsh; Vera Jankowski; Joachim Jankowski; Xi-Long Zheng
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-11       Impact factor: 5.464

Review 2.  Peripheral circulation.

Authors:  M Harold Laughlin; Michael J Davis; Niels H Secher; Johannes J van Lieshout; Arturo A Arce-Esquivel; Grant H Simmons; Shawn B Bender; Jaume Padilla; Robert J Bache; Daphne Merkus; Dirk J Duncker
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

3.  Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.

Authors:  Leonie Durnin; Sung Jin Hwang; Masaaki Kurahashi; Bernard T Drumm; Sean M Ward; Kent C Sasse; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-23       Impact factor: 11.205

4.  High salt diet exacerbates vascular contraction in the absence of adenosine A₂A receptor.

Authors:  Isha Pradhan; Darryl C Zeldin; Catherine Ledent; Jamal S Mustafa; John R Falck; Mohammed A Nayeem
Journal:  J Cardiovasc Pharmacol       Date:  2014-05       Impact factor: 3.105

5.  Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension.

Authors:  Akiyuki Nishimura; Caroline Sunggip; Hidetoshi Tozaki-Saitoh; Tsukasa Shimauchi; Takuro Numaga-Tomita; Katsuya Hirano; Tomomi Ide; Jean-Marie Boeynaems; Hitoshi Kurose; Makoto Tsuda; Bernard Robaye; Kazuhide Inoue; Motohiro Nishida
Journal:  Sci Signal       Date:  2016-01-19       Impact factor: 8.192

6.  Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism.

Authors:  Keiko Ishida; Takayuki Matsumoto; Kumiko Taguchi; Katsuo Kamata; Tsuneo Kobayashi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

7.  Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

Authors:  Julius Benicky; Roman Hafko; Enrique Sanchez-Lemus; Greti Aguilera; Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2012-07-28       Impact factor: 5.046

Review 8.  Desensitization of angiotensin receptor function.

Authors:  H Sasamura; V J Dzau; R E Pratt
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612

Review 9.  Endothelin: potential role in hypertension and vascular hypertrophy.

Authors:  E L Schiffrin
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

10.  Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation.

Authors:  Jessica R Gomolak; Sean P Didion
Journal:  Front Physiol       Date:  2014-10-29       Impact factor: 4.566

View more
  6 in total

Review 1.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

Review 2.  Purinoceptor: a novel target for hypertension.

Authors:  Xuan Li; Li-Juan Zhu; Jing Lv; Xin Cao
Journal:  Purinergic Signal       Date:  2022-02-18       Impact factor: 3.765

3.  Early Morphofunctional Changes in AngII-Infused Mice Contribute to Regional Onset of Aortic Aneurysm and Dissection.

Authors:  Lydia Aslanidou; Bram Trachet; Linda Sasset; Goran Lovric; Nikolaos Stergiopulos; Annarita Di Lorenzo
Journal:  J Vasc Res       Date:  2020-09-16       Impact factor: 1.934

4.  Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice.

Authors:  Bunyen Teng; Hicham Labazi; Changyan Sun; Yan Yang; Xiaorong Zeng; S Jamal Mustafa; Zhichao Zhou
Journal:  Purinergic Signal       Date:  2017-09-20       Impact factor: 3.765

5.  Alteration of Vascular Responsiveness to Uridine Adenosine Tetraphosphate in Aortas Isolated from Male Diabetic Otsuka Long-Evans Tokushima Fatty Rats: The Involvement of Prostanoids.

Authors:  Takayuki Matsumoto; Shota Kobayashi; Makoto Ando; Maika Iguchi; Keisuke Takayanagi; Mihoka Kojima; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Int J Mol Sci       Date:  2017-11-09       Impact factor: 5.923

6.  Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement.

Authors:  Zhichao Zhou; Oana Sorop; Vincent J de Beer; Ilkka Heinonen; Caroline Cheng; A H Jan Danser; Dirk J Duncker; Daphne Merkus
Journal:  Purinergic Signal       Date:  2017-05-24       Impact factor: 3.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.